The latest update is out from Shionogi & Co ( (JP:4507) ).

OSAKA -- Japanese pharmaceutical company Shionogi is working with Nobel laureate Shimon Sakaguchi to develop a cancer ...

The latest update is out from Shionogi & Co ( (JP:4507) ).

SAS Viya Essentials rapidly deploys select SAS Viya products using SAS Managed Cloud Services Thursday, 20 November 2025 - SAS, a global ...

Shionogi & Co. Ltd. (4507.TO) Osaka Half-Year Ended September 30 GROUP 2025 2024 Revenue Y212.97 bln Y213.97 bln Operating Profit Y74.77 bln Y75.87 bln Pretax Profit Y98.38 bln Y93.83 bln Net Profit ...

If you are on the fence about whether to buy, sell, or hold Shionogi stock, you are definitely not alone. Investors have been keeping a close eye on Shionogi’s price swings, wondering if there is more ...

Shionogi Inc., a United States subsidiary of Shionogi & Co., Ltd., (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D.), will share17 scientific presentations from across its ...

FLORHAM PARK, N.J., September 03, 2025--(BUSINESS WIRE)--Shionogi Inc., a United States subsidiary of Shionogi & Co., Ltd., (Head Office: Osaka, Japan; Chief ...

The Global Research Collaboration is a research and exclusive license option agreement with Shionogi to jointly develop novel ansamycin leads from BioVersys’ BV500 program into clinical candidates ...

Shionogi & Co. said it plans to acquire Japan Tobacco Inc. (JT) subsidiaries Torii Pharmaceutical Co. and Akros Pharma Inc. for ¥160 billion (US$1.1 billion) to expand its global R&D business. The two ...

OSAKA, Japan & SACRAMENTO, Calif.--(BUSINESS WIRE)--Shionogi & Co., Ltd. (Head Office: Osaka, Japan; President and CEO: Isao Teshirogi, PhD.; hereinafter “Shionogi ...

Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter ...